• SENSEX 72,638.70
    -429.11 (--0.59%)
  • BANKNIFTY 55,055.55
    -72.85 (--0.13%)
Back

Corporate News

Tavexia Lifecare to meet October 7th to discuss acquiring up to 60% of Meyonex Pharmaceuticals
29-Sep-2026, 09:11

Tavexia Lifecare Limited, formerly Sattva Sukun Lifecare Limited, will hold a board meeting on Wednesday, October 7, 2026, to further discuss and deliberate upon the proposed acquisition of up to 60% of the equity share capital of Meyonex Pharmaceuticals Limited, an unlisted public company with CIN: U74120MH2015PLC261024, following a previous board meeting on September 7, 2026, where the acquisition proposal was approved. The company also announced that the trading window for its securities was closed from September 30, 2026, until 48 hours after the board meeting for the approval of the un-audited financial results for the half year ended September 30, 2026.